Canadian employers and their employees can expect to see drug plan savings as generic versions of diabetes and obesity medications are introduced, cutting insurance costs. Ozempic and Wegovy – two ...

Chlorpyrifos has undergone dramatic changes in its market trajectory, from a blockbuster proprietary molecule to a globally traded generic active ingredient. AgriBusiness Global spoke with Ram ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

A terminal-based university course registration system built in Java, applying robust OOP principles and supporting roles like Students, Professors, Admins, and Teaching Assistants. Includes GPA ...

President Trump has delayed imposing tariffs on pharmaceuticals to allow for more negotiations with drug companies. (Francis Chung/Bloomberg News) The Trump administration says it doesn't plan to ...

With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Software development is one of the most rewarding careers in the world of IT. Java is one of the ...

It’s a well-worn piece of frugal advice for those looking to save money in times of economic hardship: Buy generic instead of name-brand groceries. But more and more, in-house brands are actually ...

Generic drugs made in India cause 54% more severe adverse reactions than identical drugs made in the U.S., a study finds. The issue seems to stem from regulatory oversight differences, as FDA ...